Literature DB >> 46841

Quantification of mouse macrophage chemotaxis in vitro: role of C5 for the production of chemotactic activity.

R Snyderman, M C Pike, D McCarley, L Lang.   

Abstract

Delineation of the mechanisms of macrophage accumulation at local tissue sites will further our understanding of immunologically mediated host resistance to infectious and neoplastic diseases. Since mice are frequently used for the study of immune function, we developed a method for the quantification of mouse macrophage chemotaxis in vitro. By this method it was found that the fifth component of complement is necessary for the production of chemotactic activity in mouse serum by inflammatory agents such as endotoxin or aggregated gamma globulin. The majority of macrophage chemotactic activity produced by these agents in mouse serum can be attributed to a low-molecular-weight (ca. 15,000) chemotactic factor. The data suggest that this factor is the biologically active cleavage product of the fifth component of complement, C5a.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 46841      PMCID: PMC415091          DOI: 10.1128/iai.11.3.488-492.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  In vitro studies of a chemotactic lymphokine in the guinea pig.

Authors:  S M Wahl; L C Altman; J J Oppenheim; S E Mergenhagen
Journal:  Int Arch Allergy Appl Immunol       Date:  1974

2.  Defective mononuclear leukocyte chemotaxis: a previously unrecognized immune dysfunction. Studies in a patient with chronic mucocutaneous candidiasis.

Authors:  R Snyderman; L C Altman; A Frankel; R M Blaese
Journal:  Ann Intern Med       Date:  1973-04       Impact factor: 25.391

3.  Biochemistry and biology of a leucotactic binary serum peptide system related to anaphylatoxin.

Authors:  J H Wissler; V J Stecher; E Sorkin
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

4.  The production by antigen-stimulated lymphocytes of a leukotactic factor distinct from migration inhibitory factor.

Authors:  P A Ward; H G Remold; J R David
Journal:  Cell Immunol       Date:  1970-07       Impact factor: 4.868

5.  The production of a monocyte chemotactic factor by agammaglobulinemic chicken spleen cells.

Authors:  L C Altman; H Kirchner
Journal:  J Immunol       Date:  1972-11       Impact factor: 5.422

6.  A neutrophil chemotatic factor derived from C'5 upon interaction of guinea pig serum with endotoxin.

Authors:  R Snyderman; H S Shin; J K Phillips; H Gewurz; S E Mergenhagen
Journal:  J Immunol       Date:  1969-09       Impact factor: 5.422

7.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

8.  DISTRIBUTION, INHERITANCE, AND PROPERTIES OF AN ANTIGEN, MUB1, AND ITS RELATION TO HEMOLYTIC COMPLEMENT.

Authors:  B CINADER; S DUBISKI; A C WARDLAW
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

9.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  21 in total

1.  Automated real-time measurements of leukocyte chemotaxis.

Authors:  Nacima Hadjout; Xiuyun Yin; David A Knecht; Michael A Lynes
Journal:  J Immunol Methods       Date:  2007-01-12       Impact factor: 2.303

2.  Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.

Authors:  I Kukita; T Yamamoto; T Kawaguchi; T Kambara
Journal:  Inflammation       Date:  1987-12       Impact factor: 4.092

Review 3.  Synthesis of complement by macrophages and modulation of their functions through complement activation.

Authors:  H P Hartung; U Hadding
Journal:  Springer Semin Immunopathol       Date:  1983

Review 4.  Complement components in relation to macrophage function.

Authors:  H P Hartung; U Hadding
Journal:  Agents Actions       Date:  1983-08

5.  The chemical mediation of delayed hypersensitivity skin reactions: III. Purification and characterization of a precursor protein for macrophage-chemotactic factor in normal guinea pig plasma.

Authors:  K Ueda; T Kawaguchi; T Okamoto; T Kambara
Journal:  Am J Pathol       Date:  1982-09       Impact factor: 4.307

6.  Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.

Authors:  R Snyderman; M C Pike
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

7.  Inhibition of the accumulation of macrophages and the generation of macrophage chemotactic activity by dexamethasone in concanavalin A-induced peritonitis of mice.

Authors:  I Nagaoka; H Kaneko; T Yamashita
Journal:  Agents Actions       Date:  1988-08

8.  Chemotactic and phagocytic responses of human alveolar macrophages to activated complement components.

Authors:  S W Richards; P K Peterson; H A Verbrugh; R D Nelson; D E Hammerschmidt; J R Hoidal
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

9.  Expression of macrophage functions in hybrids of a myeloma cell line with inflammatory macrophages: evidence for negative control mechanisms in the expression of macrophage functions.

Authors:  S Yamamoto; Y Higuchi
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

10.  Resistance to listeriosis in mice that are deficient in the fifth component of complement.

Authors:  J C Petit
Journal:  Infect Immun       Date:  1980-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.